Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutation.

Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutation. Am J Hematol. 2020 02; 95(2):227-229.

View in: PubMed